abstract |
The present invention relates to hexafluoroisopropanol substituted ether derivatives of formula (I), wherein R 1 to R 3 are as defined in the description and claims, and pharmaceutically acceptable salts and esters thereof. . These compounds bind to LXRα and LXRβ and can be used as pharmaceuticals. |